ZA200107999B - Formation and anion-exchange of crystalline echinocandin ammonium salts. - Google Patents

Formation and anion-exchange of crystalline echinocandin ammonium salts.

Info

Publication number
ZA200107999B
ZA200107999B ZA200107999A ZA200107999A ZA200107999B ZA 200107999 B ZA200107999 B ZA 200107999B ZA 200107999 A ZA200107999 A ZA 200107999A ZA 200107999 A ZA200107999 A ZA 200107999A ZA 200107999 B ZA200107999 B ZA 200107999B
Authority
ZA
South Africa
Prior art keywords
anion
exchange
formation
salt
ammonium salts
Prior art date
Application number
ZA200107999A
Other languages
English (en)
Inventor
Brian Weston Dadler
Michael Anthony Dotlich
Neil John Kallman
Samuel Dean Larsen
Sharon Van Den Berghe Snorek
Jeffrey Thomas Vicenzi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA200107999B publication Critical patent/ZA200107999B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/895Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896Chemical synthesis, e.g. chemical bonding or breaking
    • Y10S977/898Enzymatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA200107999A 1999-03-03 2001-09-28 Formation and anion-exchange of crystalline echinocandin ammonium salts. ZA200107999B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12307399P 1999-03-03 1999-03-03

Publications (1)

Publication Number Publication Date
ZA200107999B true ZA200107999B (en) 2003-06-25

Family

ID=22406562

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107999A ZA200107999B (en) 1999-03-03 2001-09-28 Formation and anion-exchange of crystalline echinocandin ammonium salts.

Country Status (18)

Country Link
US (1) US6590073B2 (https=)
EP (1) EP1155034B1 (https=)
JP (1) JP4063497B2 (https=)
KR (1) KR20020002476A (https=)
CN (1) CN1351610A (https=)
AT (1) ATE338060T1 (https=)
AU (1) AU767956B2 (https=)
BR (1) BR0009248A (https=)
CA (1) CA2362826A1 (https=)
CY (1) CY1105777T1 (https=)
DE (1) DE60030415T2 (https=)
DK (1) DK1155034T3 (https=)
ES (1) ES2270819T3 (https=)
HK (1) HK1040087A1 (https=)
IL (1) IL145186A0 (https=)
PT (1) PT1155034E (https=)
WO (1) WO2000052036A1 (https=)
ZA (1) ZA200107999B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
HK1040062A1 (zh) * 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方
HK1040369A1 (zh) 1999-03-03 2002-06-07 Eli Lilly And Company 制备药物口服ecb配方和组合物的方法
ATE248187T1 (de) 1999-03-03 2003-09-15 Lilly Co Eli Echinocandin-kohlenhydrate-komplexe
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102464704B (zh) * 2010-11-05 2013-12-11 上海医药工业研究院 一种化合物及其制备方法和用途
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN102295686A (zh) * 2011-09-09 2011-12-28 杭州华东医药集团生物工程研究所有限公司 一种纽莫康定b0的提取纯化方法
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) * 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN105669839B (zh) * 2014-12-05 2019-08-13 重庆乾泰生物医药有限公司 一种棘白菌素b母核或其盐的水合物及制备方法和用途
CN105669840B (zh) * 2014-12-05 2019-06-04 重庆乾泰生物医药有限公司 一种高纯度棘白菌素b母核盐酸盐的晶体及其制备方法
WO2020086931A1 (en) * 2018-10-25 2020-04-30 Cidara Therapeutics, Inc. Polymorph of echinocandin antifungal agent

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293482A (en) 1962-06-21 1966-12-20 Rca Corp Plural output traveling wave tube
JPS5134916B2 (https=) 1974-03-06 1976-09-29
CA1170598A (en) * 1979-12-13 1984-07-10 Bernard J. Abbott Process for the preparation of cyclic peptide nuclei
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4293483A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4299763A (en) 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4876241A (en) 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
CA2037957A1 (en) 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IL98349A (en) 1990-06-07 1995-05-26 Lilly Co Eli Diphylase lipopeptide
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
US5198421A (en) 1991-04-26 1993-03-30 Merck & Co., Inc. Phosphorylated cyclic lipopeptide
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
MY136593A (en) 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
EP0881907A4 (en) * 1996-02-01 2000-05-10 Lilly Co Eli FUNGICIDES IN THE FORM OF CYCLIC PEPTIDES
JPH1036284A (ja) * 1996-07-24 1998-02-10 Sumitomo Pharmaceut Co Ltd プロテアソーム阻害剤
WO1999006062A1 (en) 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
CN1240713C (zh) * 1998-02-09 2006-02-08 藤泽药品工业株式会社 化合物
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
ATE287899T1 (de) 1998-08-20 2005-02-15 Lilly Co Eli Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
CA2340647A1 (en) 1998-08-28 2000-03-09 Eli Lilly And Company Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
AU767357B2 (en) 1998-12-16 2003-11-06 Eli Lilly And Company Cyclic peptide antifungal agents
AU2189500A (en) 1998-12-16 2000-07-03 Eli Lilly And Company Cyclic peptide antifungal agents having a sugar substituent
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
HK1040369A1 (zh) 1999-03-03 2002-06-07 Eli Lilly And Company 制备药物口服ecb配方和组合物的方法
HK1040062A1 (zh) 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方
ATE248187T1 (de) 1999-03-03 2003-09-15 Lilly Co Eli Echinocandin-kohlenhydrate-komplexe

Also Published As

Publication number Publication date
DE60030415T2 (de) 2007-08-30
CY1105777T1 (el) 2011-02-02
WO2000052036A1 (en) 2000-09-08
EP1155034B1 (en) 2006-08-30
US20020161176A1 (en) 2002-10-31
HK1040087A1 (zh) 2002-05-24
DK1155034T3 (da) 2007-01-08
BR0009248A (pt) 2001-11-20
WO2000052036A8 (en) 2001-06-21
AU3718200A (en) 2000-09-21
CN1351610A (zh) 2002-05-29
KR20020002476A (ko) 2002-01-09
PT1155034E (pt) 2007-01-31
JP2002538165A (ja) 2002-11-12
ATE338060T1 (de) 2006-09-15
IL145186A0 (en) 2002-06-30
ES2270819T3 (es) 2007-04-16
EP1155034A1 (en) 2001-11-21
DE60030415D1 (de) 2006-10-12
US6590073B2 (en) 2003-07-08
CA2362826A1 (en) 2000-09-08
JP4063497B2 (ja) 2008-03-19
AU767956B2 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
IL145186A0 (en) Formation and anion-exchange of crystalline echinocandin ammonium salts
EP1514838A4 (en) METHOD FOR PRODUCING NANOTEHICLES AND NANOTEHES PRODUCED BY THE METHOD
AP1709A (en) Ethanolate of azithromycin, process for manufacure, and pharmaceutical compositions thereof.
SI9720039B (sl) Postopek za pripravo 1-alkoksikarbonil-3-fenil-propilnega derivata
WO2006045718A8 (en) Method for crystallizing soluble salts of divalent anions from brine
MY112976A (en) Process for purifying valine
JP2000256290A (ja) 安定化リジン水溶液
ES2190379A1 (es) Procedimiento de preparacion de sales de glucosamina
AU3290400A (en) A process for the preparation of gabapentin
ATE205811T1 (de) Verfahren zur herstellung von hochreinen kaliumsalzen
CA2233234A1 (en) Crystalline cellulase and method for producing same
DE3687100T2 (de) Clavamderivate, herstellung und zwischenprodukte.
US20020153261A1 (en) Method for producing basic amino acid solution
US4175206A (en) Process for preparing a hydroxyphenylglycine compound
MX9701880A (es) Proceso para producir acidos aminocarboxilicos que tienen bajo contenido de sal residual.
FR2361303A1 (fr) Procede de preparation d'hydrogenophosphate d'ammonium et de sodium et de chlorure d'ammonium a partir d'acide phosphorique obtenu par voie humide
CA2004887A1 (en) Recovery of l-amino acid isomers from their racemic mixtures
CA2227131A1 (en) Methods for the preparation of benzophenone derivatives
EP0618299B1 (en) Method for producing L-3,4-dihydroxyphenylalanine
AU6615994A (en) Recovery of organic acid salts from impure process streams by addition of bases
IE902360L (en) Resolution of an acid mixture
US20040152917A1 (en) Method of purifying glutamic acid by transition recrystallization
US5217886A (en) Method for the production of (-)-4-difluoromethyl-ornithine
SU1670000A1 (ru) Способ получени кристаллов водорастворимых соединений
AR005903A1 (es) Un proceso para la preparacion de clorhidrato en n(g)-monometil-l-arginina